Overview
Juvenile idiopathic arthritis (JIA) affecting the hip involves chronic inflammation of the hip joint in children, leading to pain, swelling, and potential joint deformity. 1Diagnosis
Persistent joint inflammation and effusion in the hip 1
Elevated inflammatory markers (e.g., ESR, CRP) 1
Exclusion of other causes through extensive testing (infectious, infiltrative diseases) 1
Clinical signs mimicking other conditions (e.g., Kawasaki syndrome) may complicate early diagnosis 1Management
First-line treatments:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation 1
- Corticosteroids (e.g., methylprednisolone) for refractory cases 1
Adjunctive treatments:
- Intravenous immunoglobulins (IVIG) if initially considered for mimicking conditions (though not primary treatment for JIA) 1
- Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate for persistent disease 1Special Populations
Pediatrics: Early diagnosis and aggressive treatment are crucial to prevent joint damage 1
Comorbidities: Presence of incomplete Kawasaki syndrome may complicate diagnosis and require differential consideration 1Key Recommendations
Initiate corticosteroid therapy for systemic onset-JIA with persistent fever and inflammatory signs unresponsive to initial treatments (Evidence: Expert opinion) 1
Employ NSAIDs early for symptom management, transitioning to DMARDs if there is no response or disease progression (Evidence: Moderate) 1
Conduct thorough differential diagnosis to rule out other inflammatory conditions, especially in atypical presentations (Evidence: Moderate) 1References
1 Rigante D, Valentini P, Onesimo R, Angelone DF, De Nisco A, Bersani G et al.. Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome. Rheumatology international 2010. link